Header cover image

Hong Kong (HSI) Healthcare Distributors Industry Analysis

UpdatedMar 18, 2024
DataAggregated Company Financials
Companies17
  • 7D0.09%
  • 3M4.2%
  • 1Y-15.8%
  • YTDn/a

The Healthcare Distributors is pretty flat in the last 7 days, but Guangzhou Baiyunshan Pharmaceutical Holdings has stood out, gaining 4.3%. Unfortunately though, the industry is down 16% over the past 12 months. Looking forward, earnings are forecast to grow by 14% annually.

Industry Valuation and Performance

Has the Hong Kong Healthcare Distributors Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 18 Mar 2024HK$135.5bHK$764.6bHK$10.4b10.4x13x0.2x
Wed, 14 Feb 2024HK$133.7bHK$761.6bHK$9.7b11.5x13.8x0.2x
Fri, 12 Jan 2024HK$132.1bHK$765.0bHK$9.7b10.8x13.6x0.2x
Sun, 10 Dec 2023HK$143.6bHK$763.6bHK$9.6b10.9x14.9x0.2x
Tue, 07 Nov 2023HK$137.8bHK$754.1bHK$9.5b12.3x14.5x0.2x
Thu, 05 Oct 2023HK$172.0bHK$750.9bHK$9.6b12.1x18x0.2x
Sat, 02 Sep 2023HK$172.0bHK$756.5bHK$9.6b11.6x17.9x0.2x
Mon, 31 Jul 2023HK$174.9bHK$735.4bHK$9.4b9x18.5x0.2x
Wed, 28 Jun 2023HK$143.6bHK$716.7bHK$11.0b8.7x13.1x0.2x
Fri, 26 May 2023HK$157.4bHK$715.2bHK$11.2b10.6x14.1x0.2x
Sun, 23 Apr 2023HK$168.3bHK$731.8bHK$11.4b10.3x14.8x0.2x
Tue, 21 Mar 2023HK$142.6bHK$720.1bHK$13.3b10.7x10.7x0.2x
Thu, 16 Feb 2023HK$134.4bHK$724.2bHK$13.2b12.6x10.2x0.2x
Sat, 14 Jan 2023HK$129.8bHK$733.3bHK$13.4b14.4x9.7x0.2x
Mon, 12 Dec 2022HK$128.7bHK$705.9bHK$12.8b12.7x10.1x0.2x
Wed, 09 Nov 2022HK$105.6bHK$689.3bHK$12.5b12.9x8.5x0.2x
Fri, 07 Oct 2022HK$58.5bHK$604.4bHK$8.3b13.3x7.1x0.1x
Sun, 04 Sep 2022HK$64.0bHK$622.7bHK$8.2b16x7.8x0.1x
Tue, 02 Aug 2022HK$67.8bHK$631.0bHK$8.6b16x7.8x0.1x
Thu, 30 Jun 2022HK$72.3bHK$634.3bHK$8.7b16.7x8.3x0.1x
Sat, 28 May 2022HK$72.2bHK$631.5bHK$8.7b14.4x8.3x0.1x
Mon, 25 Apr 2022HK$70.0bHK$646.7bHK$8.7b16.7x8.1x0.1x
Wed, 23 Mar 2022HK$70.2bHK$658.5bHK$8.9b15x7.9x0.1x
Fri, 18 Feb 2022HK$73.6bHK$644.8bHK$9.0b14.8x8.2x0.1x
Sun, 16 Jan 2022HK$71.3bHK$641.8bHK$8.9b16.7x8x0.1x
Tue, 14 Dec 2021HK$64.0bHK$641.3bHK$8.9b13.8x7.2x0.1x
Thu, 11 Nov 2021HK$67.1bHK$638.3bHK$8.9b13.5x7.5x0.1x
Sat, 09 Oct 2021HK$74.9bHK$622.3bHK$8.7b13.7x8.6x0.1x
Mon, 06 Sep 2021HK$76.5bHK$619.7bHK$8.8b16.7x8.7x0.1x
Wed, 04 Aug 2021HK$77.1bHK$619.7bHK$8.8b12.4x8.7x0.1x
Sat, 08 May 2021HK$85.5bHK$584.1bHK$8.2b12x10.4x0.1x
Price to Earnings Ratio

8.2x


Total Market Cap: HK$67.2bTotal Earnings: HK$8.2bTotal Revenue: HK$584.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Hong Kong Healthcare Distributors Industry Price to Earnings3Y Average 10.8x202220232024
Current Industry PE
  • Investors are optimistic on the Hong Kong Healthcare Distributors industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 13.1x which is higher than its 3-year average PE of 10.8x.
  • The industry is trading close to its 3-year average PS ratio of 0.15x.
Past Earnings Growth
  • The earnings for companies in the Healthcare Distributors industry have grown 8.1% per year over the last three years.
  • Revenues for these companies have grown 9.4% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Hong Kong Healthcare Distributors compare with similar industries?

HK Market1.55%
Healthcare4.12%
Healthcare Services2.81%
Healthcare Distributors0.091%
Healthcare Facilities12.11%
Healthcare Services1.29%
Managed Healthcare0%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6833 Sinco Pharmaceuticals HoldingsHK$0.264.8%
+HK$24.4m
-30.7%PE17.9x
574 Pa Shun International HoldingsHK$0.05718.8%
+HK$13.3m
n/aPS0.6x
8372 Grand Brilliance Group HoldingsHK$0.104.0%
+HK$3.2m
40.5%PE10.6x
401 Wanjia Group HoldingsHK$0.072.9%
+HK$1.1m
-55.4%PE30.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

874

HK$20.50

Guangzhou Baiyunshan Pharmaceutical Holdings

7D

-1.7%

1Y

-13.5%

1931

HK$1.78

IVD Medical Holding

7D

-6.3%

1Y

49.6%

574

HK$0.057

Pa Shun International Holdings

7D

18.8%

1Y

n/a

2289

HK$10.20

Charmacy Pharmaceutical

7D

-7.6%

1Y

43.7%

6833

HK$0.26

Sinco Pharmaceuticals Holdings

7D

4.8%

1Y

-30.7%

3390

HK$4.24

Tycoon Group Holdings

7D

-0.7%

1Y

-19.1%

1345

HK$1.36

Shanghai Pioneer Holding

7D

-2.9%

1Y

-32.3%

1099

HK$20.95

Sinopharm Group

7D

-2.3%

1Y

-8.9%

9885

HK$9.41

YSB

7D

-10.0%

1Y

n/a

9955

HK$3.57

ClouDr Group

7D

-14.4%

1Y

-44.5%

8372

HK$0.10

Grand Brilliance Group Holdings

7D

4.0%

1Y

40.5%